Roche ESMO
Biotech

Roche returns to China’s Hansoh for $15B biobucks ADC pact

A year after their first antibody-drug conjugate team-up, Roche has returned to Hansoh Pharmaceutical for a mammoth $15 billion biobucks deal.
James Waldron Oct 19, 2026 7:48am
Saudi Arabia takes actionable steps to build its biotech sector after 46 agreements in Riyadh

Saudi Arabia takes actionable steps to build its biotech sector

Merck of Germany

Merck KGaA buys Silence in $1.3B deal for blood cancer drug

Oct 19, 2026 8:57am
From Scientific Hypothesis to Clinical Practice The Next Chapter for CLDN182

The next chapter of CLDN18.2-directed innovation

Brought to you by Astellas Pharma US
AbbVie

AbbVie’s next-gen Crohn’s combo beats Skyrizi in ph. 2 test

Oct 19, 2026 5:15am
Aligning drug discovery around patient benefit from the outset Connecting human insights to better decisions

Aligning drug discovery around patient benefit from the outset: Connecting human insights to better decisions

Brought to you by IQVIA Laboratories
More News

TCGX picks migraine biotech TriGemX to take public via SPAC

Oct 19, 2026 11:05am

Fierce Biotech Layoff Tracker 2026: EyePoint halves headcount

Oct 19, 2026 11:00am

Lilly allies with Metis in $1.1B AI nanoparticle discovery deal

Oct 19, 2026 10:45am

Gilead is ‘sitting on a foundational asset’ with oral UC drug

Oct 19, 2026 9:46am